Today, one in five Americans suffer with chronic pain (~ 60 million adults) spending approximately $120 Billion a year and the aging
baby boomers have reported in surveys more aches and pains than
any previous generation.

Innolife Pharma Inc. (PINKSHEETS: INNP) is a small publicly traded specialty medical group focusing on licensing the Natural Pain Relief Center all-natural proprietary breakthrough in the treatment of chronic pain.

Over 3 years of in clinic testing showed that this breakthrough all-natural program relieved significant chronic pain in 8 out of 10 people. Most people had significant relief within 7 days that has lasted up to three years … and continues to last.

Forward-Looking Statements:
This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the companies.